WS
CPIX icon

Wedbush Securities’s Cumberland Pharmaceuticals CPIX Stock Holding History

Wedbush Securities’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-13,041
Closed -$43K – 949
2020
Q2 		$43K Buy
+13,041
New +$47.4K ﹤0.01% 918

Other funds holding CPIX

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wedbush Securities's CPIX Position: Q3 2020 in Review

Wedbush Securities sold out of Cumberland Pharmaceuticals (CPIX) in Q3 2020, closing a stake of 13,041 shares — an estimated $43K sold.

Wedbush Securities first reported a position in CPIX in Q2 2020 and held it in 1 quarter. The position peaked at $43K in Q2 2020. 27 funds tracked by Wall St. Rank hold CPIX as of Q3 2020.

  • Wedbush Securities reported no remaining Cumberland Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Wedbush Securities sold 13,041 Cumberland Pharmaceuticals shares in Q3 2020, an estimated $43K.
  • Wedbush Securities first reported a position in Cumberland Pharmaceuticals in Q2 2020 and held it in 1 quarter.
  • Wedbush Securities's Cumberland Pharmaceuticals position peaked at $43K in Q2 2020.
  • 27 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q3 2020.

Based on Wedbush Securities's 13F filing for Q3 2020, filed 20 Oct 2020.